Get startedLog in
    Picture of LAVA Therapeutics NV logo

    LVTX — LAVA Therapeutics NV News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapNeutral
    All News

    Brief: LAVA Announces Clinical Development Milestone Achieved By Pfizer For PF-08046052

    Picture of LAVA Therapeutics NV logoLAVA Therapeutics NV
    05/03/2024 12:35
    March 5 (Reuters) - LAVA Therapeutics NV  LVTX.O :
    * LAVA ANNOUNCES CLINICAL DEVELOPMENT MILESTONE ACHIEVED BY
PFIZER FOR PF-08046052 (FORMERLY SGN-EGFRD2/LAVA-1223)
    * LAVA THERAPEUTICS NV -  PFIZER ACHIEVED CLINICAL
DEVELOPMENT
MILESTONE FOR PF-08046052, PROMPTING FIRST MILESTONE PAYMENT OF
$7 MILLION TO LAVA

Source text for Eikon:  ID:nGNX7hpHgJ 
Further company coverage:  LVTX.O 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on LAVA Therapeutics NV

    See all news